Bridgeway Capital Management’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Hold |
135,270
| – | – | 0.05% | 520 |
|
|
2025
Q1 | $1.76M | Sell |
135,270
-103,692
| -43% | -$1.35M | 0.04% | 532 |
|
|
2024
Q4 | $3.18M | Sell |
238,962
-14,400
| -6% | -$192K | 0.07% | 389 |
|
|
2024
Q3 | $1.52M | Hold |
253,362
| – | – | 0.03% | 578 |
|
|
2024
Q2 | $834K | Hold |
253,362
| – | – | 0.02% | 739 |
|
|
2024
Q1 | $950K | Hold |
253,362
| – | – | 0.02% | 755 |
|
|
2023
Q4 | $1.11M | Sell |
253,362
-18,100
| -7% | -$79.3K | 0.02% | 729 |
|
|
2023
Q3 | $1.13M | Buy |
271,462
+30,000
| +12% | +$125K | 0.03% | 674 |
|
|
2023
Q2 | $843K | Hold |
241,462
| – | – | 0.02% | 769 |
|
|
2023
Q1 | $930K | Hold |
241,462
| – | – | 0.02% | 736 |
|
|
2022
Q4 | $676K | Hold |
241,462
| – | – | 0.02% | 822 |
|
|
2022
Q3 | $507K | Sell |
241,462
-25,000
| -9% | -$52.5K | 0.01% | 893 |
|
|
2022
Q2 | $698K | Buy |
266,462
+41,299
| +18% | +$108K | 0.02% | 803 |
|
|
2022
Q1 | $982K | Buy |
225,163
+21,900
| +11% | +$95.5K | 0.02% | 784 |
|
|
2021
Q4 | $872K | Buy |
203,263
+102,763
| +102% | +$441K | 0.02% | 814 |
|
|
2021
Q3 | $507K | Buy |
100,500
+25,500
| +34% | +$129K | 0.01% | 1028 |
|
|
2021
Q2 | $462K | Hold |
75,000
| – | – | 0.01% | 1089 |
|
|
2021
Q1 | $549K | Buy |
+75,000
| New | +$549K | 0.01% | 1064 |
|